Phil and Claire Drinkwater have raised more than £11,000 for charity since the loss of their 'joyful' son Jude ...
In particular, its leading candidate is hands down TSHA-102 for Rett syndrome. The way this therapy works is by using “self-complementary” adeno viruses [scAAV] to deliver its treatment.
and our commitment to making a meaningful impact for people living with Rett syndrome and their caregivers in the EU, who currently have no approved treatment options specifically for this condition,” ...
Achieving the milestone will require the company’s two marketed products, Parkinson’s disease-related psychosis med Nuplazid and newer Rett syndrome treatment Daybue, to continue on their ...
Bishop asked about upcoming events. Missling outlined the anticipated schizophrenia trial readout for ANAVEX 3-71 in the first half of 2025, the detailed ATTENTION-AD data presentation in April, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results